• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自HLA - DR1和/或 - DR4个体的细胞上存在一种新的HLA II类决定簇的证据。

Evidence for a new HLA class II determinant present on cells from HLA-DR1 and/or -DR4 individuals.

作者信息

Lepage V, Alcalay D, Douay C, Mallet C, Loiseau P, Degos L, Colombani M, Colombani J

出版信息

Tissue Antigens. 1985 Feb;25(2):96-102. doi: 10.1111/j.1399-0039.1985.tb00421.x.

DOI:10.1111/j.1399-0039.1985.tb00421.x
PMID:2581334
Abstract

Evidence for a new HLA class II specificity is presented. It is recognized by LE serum, which reacts with most DR1 and/or DR4 individuals (r = 0.86). Its frequency in the French population is 0.33. Absorption-elution experiments showed that the serum reactivity was not due to a mixture of anti-DR1 and anti-DR4 antibodies, but to a single antibody population which could be absorbed on and eluted from both DR1(+) or DR4(+) cells. LE specificity seemed to be expressed on DR but not on DQ molecules since the serum reacted with and could be absorbed by DR+,DQw- cells; it did not react with a DR-,DQw+ mutant cell, but did react with the DR+,DQw+ parental cell. The relationship between LE specificity and MC1 and Te23 specificities remains to be determined.

摘要

本文提供了一种新的人类白细胞抗原(HLA)Ⅱ类特异性的证据。它可被LE血清识别,该血清与大多数DR1和/或DR4个体发生反应(r = 0.86)。其在法国人群中的频率为0.33。吸收 - 洗脱实验表明,血清反应性并非由于抗DR1和抗DR4抗体的混合物,而是由于单一抗体群体,该群体可在DR1(+)或DR4(+)细胞上吸收和洗脱。LE特异性似乎在DR分子上表达,而不在DQ分子上表达,因为该血清与DR +、DQw - 细胞发生反应并可被其吸收;它不与DR -、DQw + 突变细胞反应,但与DR +、DQw + 亲代细胞反应。LE特异性与MC1和Te23特异性之间的关系仍有待确定。

相似文献

1
Evidence for a new HLA class II determinant present on cells from HLA-DR1 and/or -DR4 individuals.来自HLA - DR1和/或 - DR4个体的细胞上存在一种新的HLA II类决定簇的证据。
Tissue Antigens. 1985 Feb;25(2):96-102. doi: 10.1111/j.1399-0039.1985.tb00421.x.
2
A new allodeterminant on HLA-DQ molecules carrying the DQw3 specificity.携带DQw3特异性的HLA-DQ分子上的一种新的同种异体决定簇。
Hum Immunol. 1985 Dec;14(4):379-90. doi: 10.1016/0198-8859(85)90244-7.
3
Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis.一种新的HLA - DR相关决定簇MC1的血清学和细胞定义及其与类风湿性关节炎的关联。
Hum Immunol. 1984 Jul;10(3):165-76. doi: 10.1016/0198-8859(84)90037-5.
4
The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.单克隆抗体AC1.59可识别HLA-DR分子上一个新的多态性决定簇。
Tissue Antigens. 1985 Jul;26(1):25-34. doi: 10.1111/j.1399-0039.1985.tb00931.x.
5
An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.一种与HLA - DR2和DR4单倍型的转互补产物发生交叉反应的甲型流感病毒特异性且受HLA - DRw8限制的T细胞克隆。
J Immunol. 1986 Jun 1;136(11):3961-7.
6
Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.HLA-DR4纯合B细胞系上HLA-DR4、MT3和TB21抗原的分子鉴定。
J Immunol. 1984 Feb;132(2):574-7.
7
HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.HLA-DR1(DRB1*0101)和DR4(DRB1*0401)利用相同的锚定残基来结合源自人II型胶原蛋白的免疫显性肽。
J Immunol. 2002 Jan 1;168(1):253-9. doi: 10.4049/jimmunol.168.1.253.
8
Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities.两种“DR超型”特异性的进一步特征分析。更多证据表明它们存在于与携带HLA - DR位点特异性的分子不同的分子上。
Hum Immunol. 1981 Oct;3(2):93-108. doi: 10.1016/0198-8859(81)90047-1.
9
A mouse monoclonal antibody against a polymorphic determinant in a defined subset of DR molecules.
Hum Immunol. 1986 Jun;16(2):148-56. doi: 10.1016/0198-8859(86)90043-1.
10
Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4.类风湿关节炎与一种由单克隆抗体定义的多态性Ia表位的存在密切相关:与同种异体决定簇DR4的比较。
Rheumatol Int. 1984;4 Suppl:17-23. doi: 10.1007/BF00541274.

引用本文的文献

1
Two DR beta allelic series defined by exon II-specific synthetic oligonucleotide genomic hybridization: a method of HLA typing?
Proc Natl Acad Sci U S A. 1986 Oct;83(20):7836-40. doi: 10.1073/pnas.83.20.7836.
2
Comparison of human and porcine insulin therapies in children with newly diagnosed diabetes mellitus.新诊断糖尿病患儿中人类胰岛素疗法与猪胰岛素疗法的比较。
Diabetologia. 1987 Dec;30(12):912-5. doi: 10.1007/BF00295873.
3
Molecular basis of human leukocyte antigen class II disease associations.人类白细胞抗原II类疾病关联的分子基础。
Adv Immunol. 1990;48:107-59. doi: 10.1016/s0065-2776(08)60753-1.
4
Is rheumatoid arthritis in Indians associated with HLA antigens sharing a DR beta 1 epitope?印度人的类风湿性关节炎是否与共享DRβ1表位的HLA抗原相关?
Ann Rheum Dis. 1991 May;50(5):295-7. doi: 10.1136/ard.50.5.295.
5
Diversity of anti-HLA-DR antibodies elicited by distinct anti-idiotypic monoclonal antibodies recognizing idiotopes co-expressed by the immunizing monoclonal antibody.由识别与免疫单克隆抗体共表达的独特型决定簇的不同抗独特型单克隆抗体引发的抗HLA - DR抗体的多样性。
Immunology. 1992 Dec;77(4):597-603.